Drug Shortage Report for CELESTONE SOLUSPAN

Last updated on 2023-11-21 History
Report ID 182289
Drug Identification Number 00028096
Brand name CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE BETAMETHASONE ACETATE
Strength(s) 3MG 3MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR
Packaging size 1ML VIAL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-03-31
Actual start date 2023-03-15
Estimated end date 2023-11-24
Actual end date 2023-11-20
Shortage status Resolved
Updated date 2023-11-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2023-11-21 English Compare
v16 2023-11-20 French Compare
v15 2023-11-20 English Compare
v14 2023-11-17 French Compare
v13 2023-11-17 English Compare
v12 2023-08-28 French Compare
v11 2023-08-28 English Compare
v10 2023-07-07 French Compare
v9 2023-07-07 English Compare
v8 2023-05-23 French Compare
v7 2023-05-23 English Compare
v6 2023-03-16 English Compare
v5 2023-03-15 French Compare
v4 2023-03-15 English Compare
v3 2023-03-15 English Compare
v2 2023-01-25 French Compare
v1 2023-01-25 English Compare

Showing 1 to 17 of 17